Last reviewed · How we verify
NCT04168671: CLEtesting
CLE During Exercise Testing in Asthma
NA trial testing Continuous laryngoscopy during exercise test in Larynx. Withdrawn.
31 December 2021
Quick facts
| Lead sponsor | Helsinki University Central Hospital |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Start date | 1 March 2019 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Continuous laryngoscopy during exercise test
Conditions studied
- Larynx — all drugs for Larynx →
- Obstruction — all drugs for Obstruction →
- Vocal Cord Dysfunction — all drugs for Vocal Cord Dysfunction →
Sponsor
Helsinki University Central Hospital
Who can join
Adults 18 to 75, any sex, with Larynx or Obstruction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose is to assess visualize the level of laryngeal obstruction and vocal cord dysfunction and to obtain more information on causes for dyspnea in asthma and severe asthma and to assess safety of CLE in patients with asthma and with severe asthma. Patients are examined if symptomatic during exercise.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04168671
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Larynx
Currently open trials in the same condition.
- NCT03529422 — Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN · Phase 2 · active not recruiting
- NCT03854032 — Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck · Phase 2 · active not recruiting
- NCT03109171 — Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea · NA · recruiting
Other Helsinki University Central Hospital trials
Trials by the same sponsor.
- NCT07423637 — The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectivene · NA · not yet recruiting
- NCT07462559 — KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study · Phase 1 · not yet recruiting
- NCT07458984 — FMT Capsules for rCDI · Phase 3 · not yet recruiting
- NCT07001423 — ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly · NA · recruiting
- NCT07155629 — Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04168671 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helsinki University Central Hospital
- Last refreshed: 7 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04168671.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing